Trials / Completed
CompletedNCT04193631
Low Dose of Cannabidiol (CBD) to Treat Mild to Moderate Musculoskeletal Pain
A Controlled-Dose Study Using A One Time Low Dose Cannabidiol Tablet For The Treatment of Mild to Moderate Musculoskeletal Pain
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Pure Green · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to evaluate whether Pure Green tablets is a better pain reliever for the treatment of mild to moderate musculoskeletal pain.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cannabidiol (CBD) | A single dose of Cannabidiol (CBD) when patients experience musculoskeletal pain in the trial. |
Timeline
- Start date
- 2019-12-07
- Primary completion
- 2019-12-09
- Completion
- 2019-12-09
- First posted
- 2019-12-10
- Last updated
- 2020-03-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04193631. Inclusion in this directory is not an endorsement.